CAPTRUST Financial Advisors
CTXR icon

CAPTRUST Financial Advisors’s Citius Pharmaceuticals CTXR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$2K – 2502
2022
Q2 		$2K Sell
100
-284
-74% -$7.79K ﹤0.01% 4440
2022
Q1 		$17K Buy
384
+40
+12% +$1.58K ﹤0.01% 3479
2021
Q4 		$13K Buy
344
+201
+141% +$9.12K ﹤0.01% 3556
2021
Q3 		$7K Sell
143
-67
-32% -$3.36K ﹤0.01% 3797
2021
Q2 		$18K Buy
210
+110
+110% +$6.61K ﹤0.01% 3167
2021
Q1 		$4K Buy
+100
New +$3.98K ﹤0.01% 3799

Other funds holding CTXR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IA
Inspire Advisors Meridian, Idaho $1.23B AUM 18.62% 1-Year Est. Return

CAPTRUST Financial Advisors's CTXR Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Citius Pharmaceuticals (CTXR) in Q3 2022, closing a stake of 100 shares — an estimated $2K sold.

CAPTRUST Financial Advisors first reported a position in CTXR in Q1 2021 and held it in 6 quarters. The position peaked at $18K in Q2 2021. 56 funds tracked by Wall St. Rank hold CTXR as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Citius Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 100 Citius Pharmaceuticals shares in Q3 2022, an estimated $2K.
  • CAPTRUST Financial Advisors first reported a position in Citius Pharmaceuticals in Q1 2021 and held it in 6 quarters.
  • CAPTRUST Financial Advisors's Citius Pharmaceuticals position peaked at $18K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.